BNP Paribas Financial Markets Sells 135,255 Shares of DaVita Inc. (NYSE:DVA)

BNP Paribas Financial Markets cut its position in shares of DaVita Inc. (NYSE:DVA) by 25.0% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 405,195 shares of the company’s stock after selling 135,255 shares during the period. BNP Paribas Financial Markets owned about 0.46% of DaVita worth $55,937,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. First Trust Direct Indexing L.P. raised its position in DaVita by 3.9% during the 1st quarter. First Trust Direct Indexing L.P. now owns 2,590 shares of the company’s stock valued at $358,000 after purchasing an additional 98 shares in the last quarter. State of Michigan Retirement System raised its position in DaVita by 0.6% during the 4th quarter. State of Michigan Retirement System now owns 15,939 shares of the company’s stock valued at $1,670,000 after purchasing an additional 100 shares in the last quarter. GAMMA Investing LLC raised its position in shares of DaVita by 18.8% in the 1st quarter. GAMMA Investing LLC now owns 657 shares of the company’s stock worth $91,000 after acquiring an additional 104 shares in the last quarter. Meridian Wealth Management LLC raised its position in shares of DaVita by 2.9% in the 4th quarter. Meridian Wealth Management LLC now owns 5,921 shares of the company’s stock worth $620,000 after acquiring an additional 166 shares in the last quarter. Finally, Dumont & Blake Investment Advisors LLC raised its position in shares of DaVita by 2.1% in the 1st quarter. Dumont & Blake Investment Advisors LLC now owns 8,290 shares of the company’s stock worth $1,144,000 after acquiring an additional 170 shares in the last quarter. 90.12% of the stock is owned by institutional investors.

DaVita Stock Down 1.1 %

DVA stock traded down $1.50 on Friday, hitting $136.45. 863,502 shares of the company’s stock were exchanged, compared to its average volume of 940,350. DaVita Inc. has a 12-month low of $71.51 and a 12-month high of $147.93. The firm has a 50 day moving average price of $140.19 and a two-hundred day moving average price of $127.68. The company has a debt-to-equity ratio of 7.95, a quick ratio of 1.37 and a current ratio of 1.43. The stock has a market cap of $11.97 billion, a P/E ratio of 15.51, a price-to-earnings-growth ratio of 1.05 and a beta of 0.87.

DaVita (NYSE:DVA) last announced its earnings results on Thursday, May 2nd. The company reported $2.38 earnings per share for the quarter, topping the consensus estimate of $1.95 by $0.43. DaVita had a return on equity of 68.52% and a net margin of 6.61%. The firm had revenue of $3.07 billion for the quarter, compared to the consensus estimate of $3.03 billion. During the same period in the previous year, the business earned $1.58 EPS. The firm’s revenue for the quarter was up 6.9% on a year-over-year basis. As a group, equities research analysts expect that DaVita Inc. will post 9.62 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have recently commented on DVA shares. Barclays boosted their price target on DaVita from $133.00 to $150.00 and gave the stock an “equal weight” rating in a research report on Monday, May 6th. Truist Financial boosted their price target on DaVita from $135.00 to $150.00 and gave the stock a “hold” rating in a research report on Wednesday, May 15th. Finally, StockNews.com lowered DaVita from a “strong-buy” rating to a “buy” rating in a research report on Saturday, June 8th. Two analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $144.67.

Insider Buying and Selling at DaVita

In other DaVita news, Director Barbara J. Desoer sold 5,030 shares of the business’s stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $138.81, for a total transaction of $698,214.30. Following the sale, the director now owns 10,954 shares in the company, valued at approximately $1,520,524.74. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 2.00% of the company’s stock.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.